MedTrace Logo

Long-term Effects of Interventional Strategies to Prevent Cognitive Decline in Elderly.

NCT01513252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1028

Last updated 2024-06-03

No results posted yet for this study

Summary

The MAPT PLUS study is a two-year extension of follow-up of the patients included in the MAPT preventive study, after completion of the interventions. Subjects in the four groups of the MAPT study will be prospectively followed. MAPT is a multicentre, randomised, placebo-controlled study, using a 4-group design with 3 treatment groups (omega 3 alone, multi-domain intervention alone, omega 3 plus multi-domain intervention, n=420 each) and a placebo group (n=420). The MAPT PLUS study will be an extension of the MAPT study and includes an annual follow-up for two years.

Conditions

  • Frail Elderly

Interventions

BEHAVIORAL

Gröber and Buschke test

spontaneous delayed recall score after a 5 years follow-up

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Bruno Vellas, MD · University Hospital, Toulouse

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2016-04-15
Completion
2020-07-20

Countries

  • France
  • Monaco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01513252 on ClinicalTrials.gov